Blocking a muscle growth-limiting hormone protects against obesity and atherosclerosis

June 11, 2009

Knockout of myostatin, a growth factor that limits muscle growth, can decrease body fat and promote resistance against developing atherosclerosis, or "hardening" of the arteries, according to a new study conducted in mice.

"Obesity increases the risk of , which accounts for 75% of all cardiovascular events, such as heart attacks and strokes," said study co-author Shalender Bhasin, MD, professor of medicine at Boston University School of Medicine and chief of the Section of Endocrinology, Diabetes, and Nutrition at Boston Medical Center. "Current strategies aimed at preventing heart disease consist primarily of lowering cholesterol levels, but patients reaching the desired cholesterol levels are still at risk for atherosclerosis if they have other risk factors, such as obesity."

Humans and animals with a mutation in the myostatin gene are extremely muscular and have little fat, past research shows. Also, when the gene encoding myostatin is knocked out in mice, their muscle mass increases.

Bhasin and his co-workers wanted to find out if inhibiting myostatin in mice could resist the development of diet-induced obesity and of atherosclerosis, the buildup of lipid deposits called plaque that can narrow and clog coronary arteries.

The researchers took mice that were genetically altered to develop atherosclerosis and then cross-bred them with myostatin knockout mice. Ten generations later, they had mice who were genetically predisposed to both atherosclerosis and inactivation of myostatin. For controls, they studied mice with a genetic predisposition for atherosclerosis but with intact myostatin gene. All mice received a high-fat diet for 12 weeks, to spur the development of atherosclerosis.

Compared with controls, the mice with deleted myostatin gene had much less body fat and 30 percent lower fasting blood sugar and 80% lower fasting insulin levels, showing a reduction in obesity and a strong resistance to developing diabetes, the authors reported. They also had 50 percent lower low-density-lipoprotein ("bad") cholesterol and 30 to 60 percent lower levels of total cholesterol and triglycerides (fats in the blood), respectively. These results indicate protection against the development of atherosclerosis, according to Bhasin.

More research is needed to demonstrate the safety and effectiveness of myostatin inhibitors in humans, Bhasin said. However, he said that that this therapeutic strategy already is possible. Experimental drugs called myostatin blockers or inhibitors are being studied as potential treatments of muscle wasting disorders and limb injuries.

Some currently available nutritional supplements are touted as myostatin inhibitors, but Bhasin said he doubts they are effective.

Source: The Endocrine Society (news : web)

Explore further: New kind of mutation is reported

Related Stories

New kind of mutation is reported

June 5, 2006

Belgium scientists say they have discovered a new kind of mutation that might be at the origin of many phenotypes in various species.

'Mighty mice' made mightier

August 29, 2007

The Johns Hopkins scientist who first showed that the absence of the protein myostatin leads to oversized muscles in mice and men has now found a second protein, follistatin, whose overproduction in mice lacking myostatin ...

Muscling in on type 2 diabetes

February 26, 2009

Research by kinesiology investigator Dustin Hittel, PhD, has proven that muscle in extremely obese individuals produces large amounts of a protein called myostatin, which normally inhibits muscle growth--suggesting that for ...

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

( -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...


Adjust slider to filter visible comments by rank

Display comments: newest first

4 / 5 (1) Jul 06, 2009
OK, here we go. MYO-T12. That's the new myostain product. Anybody else see this over at Looks like someone's finally got a handle on this technology. Obviously, it always pays to be skeptical, but man, if it works this would be huge! Anybody else going to try this when it comes out (they're saying September).
not rated yet Aug 07, 2009
I have seen this product on Prosource website. They had another similar product a year ago and was really bragging it up and then before the release date, it vanished. They didn't have an explanation or anything. Anyways, Myo-T12 is available now for 100 bucks for a 30 day supply. I am pretty sceptical myself. You can sell a rock online and write up a 5 page article on how it will stop arthritis simply by holding it in your hand. I am going to wait and see if there is some positive LEGITIMATE feedback before I start throwing my money at them. It would be sweet if this product was the real deal.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.